SETTLEMENT SHINES LIGHT ON NOMINAL PRICING
November 4, 2011
GlaxoSmithKline's settlement over "nominal pricing" practices in the US reflects a long-running dispute between regulators and many pharmaceutical companies over their handling of drug reimbursement ...
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Settlement News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
